Maravai LifeSciences Acquires DNA and RNA Business from Officinae Bio
Deal News | Nov 11, 2024 | PedersoliGattai
Maravai LifeSciences, a publicly traded American life sciences company, has entered into an agreement to acquire the DNA and RNA business from Officinae Bio, an Italian private technology company known for its proprietary digital platform supporting the design of innovative therapies. The transaction's completion, scheduled for early 2025, hinges on the fulfillment of certain conditions. Maravai LifeSciences received legal advice from PedersoliGattai, whose multidisciplinary team was led by partner Gerardo Gabrielli, with assistance from counsel Cristina Riva and associate Chiara Guidi on corporate matters. Senior counsel Nicola Martegani and senior associate Clara Balboni handled due diligence, while partner Davide Cacchioli, salary partner Alessandro Bardanzellu, and associate Martina Oricco managed antitrust and golden power profiles.
Sectors
- Life Sciences
- Biotechnology
- Legal Advisory
Geography
- United States – Maravai LifeSciences is an American company involved in the transaction.
- Italy – Officinae Bio, the target company in the acquisition, is based in Italy.
Industry
- Life Sciences – Maravai LifeSciences operates in the life sciences sector, providing reagents and services to researchers and biotech innovators.
- Biotechnology – Officinae Bio is involved in biotechnology, utilizing a digital platform for the design of innovative therapies.
- Legal Advisory – PedersoliGattai provided legal advisory services for the acquisition, demonstrating relevance to the legal advisory sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Maravai LifeSciences, Inc. | Bidding Company | Company | A global provider of life science reagents and services to researchers and biotech innovators, involved in acquiring Officinae Bio's DNA and RNA business. |
| Officinae Bio | Target Company | Company | An Italian private technology company with a proprietary digital platform for biological therapy design. |
| PedersoliGattai | Legal Advisor | Company | Provided legal advisory services to Maravai LifeSciences in the acquisition deal. |
| Gerardo Gabrielli | Partner | Person | Led the PedersoliGattai team advising Maravai LifeSciences on corporate matters. |
| Cristina Riva | Counsel | Person | Part of the PedersoliGattai team handling corporate aspects of the acquisition. |
| Chiara Guidi | Associate | Person | Assisted in the corporate aspects of the acquisition at PedersoliGattai. |
| Nicola Martegani | Senior Counsel | Person | Handled due diligence for the acquisition at PedersoliGattai. |
| Clara Balboni | Senior Associate | Person | Involved in managing due diligence at PedersoliGattai. |
| Davide Cacchioli | Partner | Person | Managed antitrust and golden power profiles in the acquisition at PedersoliGattai. |
| Alessandro Bardanzellu | Salary Partner | Person | Part of the team at PedersoliGattai involved in antitrust and golden power matters. |
| Martina Oricco | Associate | Person | Assisted in antitrust and golden power profiles at PedersoliGattai. |